BCL6 and infection: Consistent with enhanced humoral immunity, we found α-IFNAR treatment resulted in 2 to 3-fold expansions in the frequency and total number of Plasmodium-infection-induced (S1C Fig) splenic PD-1+CXCR5+Bcl-6+ Tfh cells (Fig 2A–2D).